Trademark: 88885974
Status Date
Wednesday, January 13, 2021
Filing Date
Friday, April 24, 2020
Published for Opposition
Tuesday, August 25, 2020
5 Recombinant albumin for use as a reagent for medical use, namely, in-vitro fertilization, tissue sealant, tissue and cell cryopreservation, and blood detoxification; Vaccine stabilizers
1 Recombinant albumin in the nature of excipients for use in the manufacture of pharmaceutical preparations, veterinary preparations, cellular therapies, gene therapies, regenerative medicines, and vaccines; Recombinant albumin for use as a reagent for scientific and research use, namely, biomedical research and development; Cell culture reagents for scientific and research use; Biological preparations for use in cell cultures other than for medical or veterinary use
Sep 13, 2023
Automatic Update Of Assignment Of Ownership
Apr 7, 2021
Changes/Corrections After Pub Approval Entered
Apr 7, 2021
Assigned To Petition Staff
Jan 13, 2021
Extension Of Time To Oppose Process - Terminated
Dec 18, 2020
Teas Post Publication Amendment Received
Sep 18, 2020
Extension Of Time To Oppose Received
Aug 25, 2020
Official Gazette Publication Confirmation E-Mailed
Aug 25, 2020
Published For Opposition
Aug 5, 2020
Notification Of Notice Of Publication E-Mailed
Jul 20, 2020
Approved For Pub - Principal Register
Jul 19, 2020
Assigned To Examiner
May 5, 2020
New Application Office Supplied Data Entered
Apr 28, 2020
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
